Literature DB >> 14751828

The therapeutic potential of antigen-oligonucleotide conjugates.

Sandip K Datta1, Kenji Takabayashi, Eyal Raz.   

Abstract

Conjugation of protein antigen with immunostimulatory oligonucleotides creates a potent immunogen that elicits antigen-specific antibody responses, a Th1-biased cytokine profile, and CD8 cytotoxic T lymphocyte activity. The wide range of humoral and cellular immune responses induced by these conjugates suggests they can be used to create effective vaccines against infectious pathogens and tumors and to beneficially modulate the immune responses seen in allergic diseases. This review summarizes the available data on the use of antigen-oligonucleotide conjugates and discusses their potential use for the treatment of infectious, oncologic, and allergic diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14751828     DOI: 10.1196/annals.1281.022

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

Review 1.  Innovative strategies for co-delivering antigens and CpG oligonucleotides.

Authors:  Yogita Krishnamachari; Aliasger K Salem
Journal:  Adv Drug Deliv Rev       Date:  2009-01-19       Impact factor: 15.470

Review 2.  Ultrasonic-activated micellar drug delivery for cancer treatment.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

3.  Immunostimulatory sutures that treat local disease recurrence following primary tumor resection.

Authors:  Janjira Intra; Xue-Qing Zhang; Robin L Williams; Xiaoyan Zhu; Anthony D Sandler; Aliasger K Salem
Journal:  Biomed Mater       Date:  2011-01-05       Impact factor: 4.103

4.  Comparative Study of 5'- and 3'-Linked CpG-Antigen Conjugates for the Induction of Cellular Immune Responses.

Authors:  Katrin Kramer; Sarah L Young; Greg F Walker
Journal:  ACS Omega       Date:  2017-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.